Stockwire

Why Chambal Fertilisers trades at 8 times earnings

India needs more urea, and Chambal is weighing a Rs 10,000 crore expansion. But the pricing arrangement behind its most profitable plant ends in December 2026.

India needs more urea, and Chambal is weighing a Rs 10,000 crore expansion. But the pricing arrangement behind its most profitable plant ends in December 2026.Anand Kumar/AI-Generated Image

हिंदी में भी पढ़ें read-in-hindi

Summary: Chambal Fertilisers just had its best year in five, yet the market will pay only a modest multiple for it. The reason may sit inside a single plant and a pricing deal with an expiry date. The question is how much of today's profit outlives it.

Chambal Fertilisers earned Rs 1,953 crore in FY26, its best year in five, yet trades at eight times earnings and 1.5 times book value. Return on equity is nearly 19 per cent. It is weighing a Rs 10,000 crore urea plant and has commissioned a Rs 1,645 crore chemicals facility.

The catch: the pricing arrangement behind Gadepan-III, its most profitable urea plant, expires in December 2026. IIFL Capital estimates the plant earns 53 per cent of the urea segment’s profit. Is the market expecting a fall in earnings that is not yet visible?

India needs more urea than it makes

Urea consumption grew about 3.8 per cent annually over FY22-26, while production in FY26 was below FY24. Imports reached 104 lakh tonnes in FY26, or 26 per cent of consumption.

India’s urea market (lakh tonnes) FY22 FY24 FY26
Consumption 342 358 397
Domestic production 251 314 293
Imports 91 70 104
Source: Department of Fertilisers. Gaps reflect inventory changes.

A July 2026 policy offers eligible new plants a 12-16 per cent return on equity, and Chambal could add 13 lakh tonnes at Gadepan, nearly 40 per cent more.

Policy, not prices, sets urea profits

Indian urea makers cannot set prices: farmers pay a government-controlled price and manufacturers receive prescribed subsidies. Profit depends on energy efficiency and policy, not just global prices. Chambal’s three Gadepan plants beat the prescribed energy benchmarks.

FY26 segments Revenue (Rs crore) Share (%) Profit (Rs crore) Share (%)
Manufactured urea 12,566 60.4 1,845 76.6
Complex fertilisers 7,025 33.8 281 11.7
Crop protection, speciality nutrients and seeds 1,203 5.8 283 11.7
Total 20,794 100 2,409 100
Source: FY26 audited segment results. Profit is earnings before interest and tax, before unallocated items and finance costs.

Gadepan-III’s pricing deal ends in December

Commissioned in January 2019, Gadepan-III runs under the New Investment Policy of 2012 (NIP-2012), which links its selling price to international urea prices within gas-adjusted minimum and maximum limits. After December 2026, the plant falls under the applicable government pricing framework, whose treatment is undecided.

The difficulty is depreciation. Gadepan-III will have run only eight years, while older calculations assumed 15-year depreciation. Applying that method without recognising its remaining capital investment could cut profit sharply.

IIFL Capital estimates Gadepan-III’s FY26 earnings before interest and tax at Rs 7,650 a tonne, against Rs 4,200 at Gadepan-I and II. On 12.7 lakh tonnes, that is about Rs 972 crore, or 53 per cent of urea profit. IIFL expects Rs 4,400 a tonne by FY28, almost erasing the advantage. This is an analyst estimate, not an approved government formula. CRISIL separately flags the transition as a significant profitability risk.

Older-plant parity cuts profit 17 per cent

If Gadepan-III’s profit falls to the older plants’ Rs 4,200 a tonne, profit after tax falls to Rs 329 crore, or 16.8 per cent of FY26’s.

Scenario No change Partial reduction Older-plant parity
Gadepan-III profit per tonne (Rs) 7,650 6,150 4,200
Fall in segment profit (Rs crore) 0 191 438
Fall in profit after tax (Rs crore) 0 143 329
Adjusted profit after tax (Rs crore) 1,953 1,810 1,625
Price-to-earnings (P/E) ratio at Rs 390 (times) 8 8.6 9.6
Based on FY26 consolidated profit after tax, 12.7 lakh tonnes and 25 per cent tax. Plant-wise figures are IIFL estimates; the partial reduction is illustrative.

The impact could begin in the January-March 2027 quarter, making FY28 the first full year exposed.

Other businesses need time

Crop protection, speciality nutrients and seeds earned Rs 283 crore in segment profit on Rs 1,203 crore of revenue; Chambal’s distribution network supports further growth.

Its technical ammonium nitrate (TAN) plant began commercial production in August 2026. With 2.4 lakh tonnes of annual capacity, it makes an industrial chemical used mainly in mining explosives. Deepak Fertilisers’ TAN subsidiary posted a 37.3 per cent margin on earnings before interest, tax, depreciation and amortisation in the first nine months of FY26. At 80 per cent utilisation, Rs 45,000 a tonne and a lower 30 per cent margin on that measure, Chambal’s plant could earn about Rs 260 crore a year.

But Deepak is adding 3.76 lakh tonnes too. Together, the additions exceed India’s recent ammonium nitrate imports, which may pressure prices and delay any offset.

Cash flow and pledges add risk

The proposed fourth urea plant could lift earnings after 2030, but it lacks final sanction and needs substantial funding. Cash generation is weak: Rs 1,953 crore of FY26 profit produced only Rs 138 crore of operating cash flow, as working capital absorbed cash.

As at September 2026, promoters had pledged about 5.22 crore shares, or 13.0 per cent of equity, down from 14.2 per cent in June. Promoter-group company Zuari Industries has used them to secure its own borrowings and loans taken by subsidiaries. Zuari had about Rs 1,160 crore of standalone borrowings at March 2026.

Downside: higher multiple, lower returns

Chambal looks inexpensive at about eight times FY26 earnings, and its 1.5 times book value is below recent valuation levels. If Gadepan-III’s profit converges with the older plants’, the multiple rises to 9.6 times and return on FY26 closing equity falls from about 19 per cent to 16 per cent. Expansion that raises invested capital before it earns meaningful profit would weaken the case further.

A favourable transition, with growing TAN and crop protection profits, could preserve returns and support a valuation recovery. A sharp fall at Gadepan-III, weak returns on new investment or promoter-linked selling could justify today’s discount.

The discount is real, and so is the risk. What matters is less FY26’s reported profit than how much of it survives the transition and the next investment cycle.

Also read: Coal India has brought turmoil to the doorstep of these 3 chemical giants

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Other Categories